[1]孙青青　任洪波　牛国栋.lncRNA SNHG16在人脑胶质瘤组织中的表达及其与病人预后的关系[J].中国临床神经外科杂志,2020,(12):831-833.[doi:10.13798/j.issn.1009-153X.2020.12.005]
　SUN Qing-qing,REN Hong-bo,NIU Guo-dong..Expression of lncRNA SNHG16 in human glioma tissues and its relationship with prognosis of glioma patients[J].,2020,(12):831-833.[doi:10.13798/j.issn.1009-153X.2020.12.005]
点击复制

lncRNA SNHG16在人脑胶质瘤组织中的表达及其与病人预后的关系()
分享到：

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
期数:
2020年12期
页码:
831-833
栏目:
论著
出版日期:
2020-12-25

文章信息/Info

Title:
Expression of lncRNA SNHG16 in human glioma tissues and its relationship with prognosis of glioma patients
文章编号:
1009-153X（2020）12-0831-03
作者:
孙青青　任洪波　牛国栋
056000 河北，邯郸市中心医院神经外三科（孙青青、任洪波、牛国栋）
Author(s):
SUN Qing-qing;  REN Hong-bo;  NIU Guo-dong.
Department of Neurosurgery, Handan Central Hospital, Handan 056000, China
关键词:
胶质瘤; 长链非编码RNA; 核内小RNA宿主基因16; 预后; 影响因素
Keywords:
Glioma;  Long chain noncoding RNA;  Small nucleolar RNA host gene 16;  Prognosis
分类号:
R 739.41; Q 786
DOI:
10.13798/j.issn.1009-153X.2020.12.005
文献标志码:
A
摘要:
目的 探讨长链非编码RNA（lncRNA）SNHG16在人脑胶质瘤组织中的表达及其与病人预后的关系。方法 实时荧光定量PCR检测104例2013年9月至2015年1月本院病理科冻存的胶质瘤组织和2018年4月至2019年1月颅脑损伤内减压术中切除的40例正常脑组织lncRNA SNHG16的相对表达量。以SNHG16表达量的中位数为截断值，将胶质瘤病人分为高表达组和低表达组。随访截止时间为2019年6月，记录总生存期（OS）和无进展生存期（PFS）。结果 胶质瘤组织SNHG16相对表达量明显高于正常脑组织（P<0.001）；高级别胶质瘤组织SNHG16相对表达量明显高于低级别胶质瘤组织（P<0.001）。多因素Cox比例回归风险模型分析结果显示，SNHG16高表达是胶质瘤病人OS和PFS缩短的独立危险因素（P<0.05）。生存曲线分析显示高表达组OS（中位数25个月，四分位数18~34个月）和PFS（中位数15个月，四分位数9~18个月）较低表达组（OS中位数35个月，四分位数20~42个月；PFS中位数19个月，四分位数12~20个月）明显缩短（P<0.05）。结论 人脑胶质瘤SNHG16呈高表达，与病人不良生存预后和肿瘤进展有关。
Abstract:
Objective To investigate the expression of long non-coding RNA (lncRNA) small nucleolar RNA host gene 16 (SNHG16) in human glioma tissues and its relationship with the prognosis of glioma patients. Methods Real-time fluorescence quantitative PCR was used to detect the relative expression level of lncRNA SNHG16 in glioma tissues obtained from 104 patients with glioma who underwent mocirosurgery from September 2013 to January 2015 and in normal cerebral tissues obtained from 40 patients with traumatic brain injury who underwent decompression from April 2018 to January 2019. Taking the median of SNHG16 expression as the cut-off value, glioma patients were divided into high expression group and low expression group. The deadline for follow-up was June 2019, and overall survival (OS) and progression-free survival (PFS) were recorded. Results The relative expression level of SNHG16 in glioma tissues was significantly higher than that in normal cerebral tissues (P<0.05). The relative expression level of SNHG16 in high-grade glioma tissues was significantly higher than that in low-grade glioma tissues (P<0.05). The multivariate Cox proportional regression risk model analysis showed that high expression of SNHG16 was risk factors for shorter OS and PFS of glioma patients (P<0.05). The OS and PFS of the low expression group were significantly higher than those of the high expression group (P<0.05). Conclusions The lncRNA SNHG16 is highly expressed in human gliomas. The high expression of SNHG16 is related to the poor survival prognosis and tumor progression of glioma patients.

参考文献/References:

[1] Gusyatiner O, Hegi ME. Glioma epigenetics: from subclas-sification to novel treatment options [J]. Semin Cancer Biol, 2018, 51: 50-58.
[2] Bhan A, Soleimani M, Mandal SS. Long noncoding RNA andcancer: a new paradigm [J]. Cancer Res, 2017, 77(15): 3965-3981.
[3] Wang X, Kan J, Han J, et al. LncRNA SNHG16 functions as an oncogene by sponging mir-135a and promotes JAK2/STAT3 signal pathway in gastric cancer [J]. J Cancer, 2019, 10(4): 1013-1022.（下转第837页）（上接第833页）
[4] Xu F, Zha G, Wu Y, et al. Overexpressing lncRNA SNHG16 inhibited HCC proliferation and chemoresistance by func-tionally sponging hsa-miR-93 [J]. Onco Targets Ther, 2018,11: 8855-8863.
[5] Liu S, Zhang W, Liu K, et al. LncRNA SNHG16 promotes tumor growth of pancreatic cancer by targeting miR-218-5p[J]. Biomed Pharmacother, 2019, 114: 1-8.
[6] 王嘉新，姜兴明. 肿瘤发生发展中SNHG16的调控作用及机制研究[J]. 现代医学，2019，47（3）：350-353.
[7] Gong CY, Tang R, Nan W, et al. Role of SNHG16 in human cancer [J]. Clin Chim Acta, 2020, 503: 175-180.
[8] Zhou XY, Liu H, Ding ZB, et al. lncRNA SNHG16 promotesglioma tumorigenicity through miR-373/EGFR axis by acti-vating PI3K/AKT pathway [J]. Genomics, 2020, 112(1): 1021-1029.
[9] Christensen LL, True K, Hamilton MP, et al. SNHG16 is regulated by the Wnt pathway in colorectal cancer and affects genes involved in lipid metabolism [J]. Mol Oncol, 2016, 10(8): 1266-1282.
[10] Zhou C, Zhao J, Liu J, et al. LncRNA SNHG16 promotes epithelial- mesenchymal transition via down-regulation of DKK3 in gastric cancer [J]. Cancer Biomark, 2019, 26(4): 393-401.
[11] 朱晓鸿，赵娟娟，刘娟娟，等. 下调SNHG16对胃癌细胞HGC-27细胞周期的影响[J]. 贵州医药，2017，41（12）： 1242-1244.
[12] An JH, Chen ZY, Ma QL, et al. LncRNA SNHG16 promotedproliferation and inflammatory response of macrophages through miR-17-5p/NF-κB signaling pathway in patients with atherosclerosis [J]. Eur Rev Med Pharmacol Sci, 2019, 23(19): 8665-8677.
[13] 欧阳一彬，莫业和，何青龙，等. 影响脑胶质瘤患者生存和预后的相关因素分析[J]. 河北医药，2018，40（10）：1524-1526，1530.
[14] 李德培，陈银生，郭琤琤，等. 脑胶质瘤的临床疗效和预后因素分析（附741例报告）[J]. 中华神经外科杂志，2018，34（9）：905-909.

相似文献/References:

[1]常英男　王　策　赵天书.SOX2基因在胶质瘤中的表达及生物学作用[J].中国临床神经外科杂志,2016,(05):270.[doi:10.13798/j.issn.1009-153X.2016.05.005]
　CHANG Ying-nan,WANG Ce,ZHAO Tian-shu..Expression of SOX2 gene and its biological role in human gliomas[J].,2016,(12):270.[doi:10.13798/j.issn.1009-153X.2016.05.005]
[2]赛　克　陈忠平.胶质瘤的疗效评价[J].中国临床神经外科杂志,2016,(06):321.[doi:10.13798/j.issn.1009-153X.2016.06.001]
[3]许　耿　路俊锋　杨　忠　施建斌　吴秋月　王　烨　庄冬晓　吴劲松.神经电生理监测技术在功能区胶质瘤术中的应用[J].中国临床神经外科杂志,2016,(06):323.[doi:10.13798/j.issn.1009-153X.2016.06.002]
　XU Geng,LU Jun-feng,YANG Zhong,et al.Application of intraoperative neuroelectrophysiologic monitoring to gliomas resection in eloquent function brain regions[J].,2016,(12):323.[doi:10.13798/j.issn.1009-153X.2016.06.002]
[4]李剑峰　陈银生　赛　克　张湘衡　柯　超　杨群英　牟永告　许海雄　陈忠平.173例胶质瘤预后的影响因素分析[J].中国临床神经外科杂志,2016,(06):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
　LI Jian-feng,CHEN Yin-sheng,SAI Ke,et al.Prognostic factors for gliomas: analysis of 173 cases[J].,2016,(12):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
[5]云德波　杨宇焦　张　逵　范润金　张　渊　杜贻庆.瘤周谷氨酸、天门冬氨酸水平与胶质瘤继发性 癫痫的相关性[J].中国临床神经外科杂志,2016,(06):331.[doi:10.13798/j.issn.1009-153X.2016.06.004]
　YUN De-bo,YANG Yu-Jiao,ZHANG Kui,et al.Relationship of levels of glutamate and aspartate in peritumorous tissues with seizures in patients with gliomas[J].,2016,(12):331.[doi:10.13798/j.issn.1009-153X.2016.06.004]
[6]黄书岚　成于思　王　辉　汪超甲.FAK siRNA重组质粒的构建及其对胶质瘤U251细胞 增殖及侵袭能力的抑制作用[J].中国临床神经外科杂志,2016,(06):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
　HUANG Shu-lan,CHENG Yu-si,WANG Hui,et al.Construction of siRNA recombinant plasmid targeting focal adhesion kinase gene and its effect on the proliferation and invasiveness of human glioma U251cells[J].,2016,(12):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
[7]林　雨　张　恺　李　帅　杨学军.磁共振数字化手术单元在指导胶质瘤治疗中的作用[J].中国临床神经外科杂志,2016,(06):345.[doi:10.13798/j.issn.1009-153X.2016.06.009]
[8]戴黎明　徐成仕　王泽芬　曹长军　李志强.VEGF单抗对低氧环境下C6胶质瘤细胞侵袭性的影响[J].中国临床神经外科杂志,2016,(04):219.[doi:10.13798/j.issn.1009-153X.2016.04.009]
　DAI Li-ming,XU Cheng-shi,WANG Ze-fen,et al.Effect of nonoclonal antibody of VEGF on C6 glioma cells invasiveness under hypoxia and the role of FAK/Pyk2[J].,2016,(12):219.[doi:10.13798/j.issn.1009-153X.2016.04.009]
[9]彭泽生　田道锋　张申起　陈谦学.miR-370-3p对胶质母细胞瘤U87-MG细胞株增殖能力的影响[J].中国临床神经外科杂志,2016,(04):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
　PENG Ze-sheng,TIAN Dao-feng,ZHANG Shen-qi,et al.Effects of MircoRNA-370-3p on proliferation of glioma cell line U87-MG and its potential mechanism[J].,2016,(12):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
[10]冯　驰　郭双毅　程龙海　罗　杰.氯喹通过抑制自噬促进TRAIL诱导的胶质瘤细胞凋亡[J].中国临床神经外科杂志,2016,(04):227.[doi:10.13798/j.issn.1009-153X.2016.04.011]
　FENG Chi,GUO Shuang-yi,CHENG Long-hai,et al.Chloroquine promotes TRAIL-induced apoptosis of glioma cells through inhibition of autophagy[J].,2016,(12):227.[doi:10.13798/j.issn.1009-153X.2016.04.011]
[11]谈胤求　陈谦学　张红波　吴　鹏　李云涛　王栋良　袁凡恩.长链非编码RNA PVT1对人脑胶质瘤U251细胞增殖能力的影响[J].中国临床神经外科杂志,2016,(10):608.[doi:10.13798/j.issn.1009-153X.2016.10.013]
　TAN Yin-qiu,CHEN Qian-xue,ZHANG Hong-bo,et al.Effect of lncRNA-PVT1 on proliferation of glioma U251 cells[J].,2016,(12):608.[doi:10.13798/j.issn.1009-153X.2016.10.013]
[12]陈　波　云亚滨　杜俊峰　王伟志.lncRNA SNHG16对胶质瘤U251细胞增殖、侵袭和迁移的影响[J].中国临床神经外科杂志,2020,(11):771.[doi:doi:10.13798/j.issn.1009-153X.2020.11.012]
　CHEN Bo,YUN Ya-bin,DU Jun-feng,et al.Effect of lncRNA SNHG16 on proliferation, invasion and migration of glioma U251 cells[J].,2020,(12):771.[doi:doi:10.13798/j.issn.1009-153X.2020.11.012]
[13]郑江林　王　旋　汪珉杰　姜晓兵.人脑胶质瘤lncRNA PIK3CD-AS2表达及临床意义[J].中国临床神经外科杂志,2021,26(09):687.[doi:10.13798/j.issn.1009-153X.2021.09.011]
　ZHENG Jiang-lin,WANG Xuan,WANG Min-jie,et al.Expression of lncRNA PIK3CD-AS2 in human brain gliomas and its clinical significance[J].,2021,26(12):687.[doi:10.13798/j.issn.1009-153X.2021.09.011]
[14]李占成　石　铁　周卫忠.胶质瘤自噬相关长链非编码RNA的生信分析[J].中国临床神经外科杂志,2021,26(11):839.[doi:10.13798/j.issn.1009-153X.2021.11.007]
　LI Zhan-cheng,SHI Tie,ZHOU Wei-zhong.Autophagy-related long non-coding RNA signature in glioma patients based on bioinformatics analysis[J].,2021,26(12):839.[doi:10.13798/j.issn.1009-153X.2021.11.007]
[15]杨帆,综述,张剑宁,等.长链非编码RNA在胶质瘤中的研究进展[J].中国临床神经外科杂志,2022,27(06):508.[doi:10.13798/j.issn.1009-153X.2022.06.028]
[16]陈操,综述,陈铎,等.lncRNA在胶质瘤放化疗中作用的研究进展[J].中国临床神经外科杂志,2022,27(07):610.[doi:10.13798/j.issn.1009-153X.2022.07.029]
[17]王昆鹏,张建党,董孟宁,等.lncRNA SNHG7对胶质瘤细胞侵袭、迁移的影响[J].中国临床神经外科杂志,2022,27(08):662.[doi:10.13798/j.issn.1009-153X.2022.08.012]
　WANG Kun-peng,ZHANG Jian-dang,DONG Meng-ning,et al.[J].,2022,27(12):662.[doi:10.13798/j.issn.1009-153X.2022.08.012]
[18]丁萌,王红娟,周洁,等.lncRNA ZNF674-AS1过表达对胶质瘤U87细胞增殖、侵袭和迁移的影响[J].中国临床神经外科杂志,2022,27(10):837.[doi:10.13798/j.issn.1009-153X.2022.10.012]
　DING Meng,WANG Hong-juan,Zhou Jie,et al.Effects of over-expression of lncRNA ZNF674-AS1 on proliferation, invasion and migration of U87 glioma cells[J].,2022,27(12):837.[doi:10.13798/j.issn.1009-153X.2022.10.012]

更新日期/Last Update: 2020-12-25